Innovations in 3D printing are marching toward us, in droves, faster than most people can keep up with today. There are so many, in fact, that it’s easy to start becoming desensitized to the stunning impacts many of these improvements and completely new inventions are allowing.
It’s good to see some things becoming so common that we are now used to hearing about them–like 3D printed prosthetics. But still, there are many different complexities to be explored with this technology that either has or is on the verge of transforming so many processes in ways we just never considered. And many of these more complex technologies are still being developed behind the scenes.
Why aren’t we seeing even more complex functions in 3D printing from the genius of the world, however? It would seem we should be able to do just about anything we want to at this point. This subject was recently covered in a paper ‘3D Printable Antimicrobial Composite Resins,’ published in the Advanced Functional Materials journal.
Ongoing studies by the researchers at the University of Groningen in the Netherlands have resulted in ‘expanding on the repertoire of 3D printable materials to include antimicrobial polymer resins.’ This is really of enormous significance, simple as it sounds, as it could lead to the elimination of some infections.
“Although 3D printed objects composed of metals, ceramics, polymers, and even cell-loaded hydrogels have been realized, the development of materials with integrated functions amenable for 3D printing has been slow,” state the researchers.
“…since many medical device surfaces attract microorganisms, engineering an intrinsic antimicrobial functionality in or onto implantable medical devices can reduce the risk of microbial infections associated with the presence of a foreign material in the human body.”
These antimicrobial resins, as applied to 3D print, could have the extremely important ability to prevent major illnesses. And these researchers in the Netherlands have made significant progress through the invention of a 3D printed plastic that actually eliminates bacteria directly upon contact.
So far, the researchers have created 3D printed models that could be used in dental applications, fabricating numerous dental items like implants and orthodontics, cured with UV light. Using dental resins, the incredible benefit comes from the embedded antimicrobial quaternary ammonium salts inside the polymers. Because they are positively charged, they quickly cause negatively charged bacterial membranes to burst and die.
While they’ve just begun with the dental arena, the potential is of course enormous. Just in the case of the dental realm, the ability to stop infections caused by dentures and implants would be invaluable. So far, they are able to kill nearly all the bacteria causing tooth decay within their study. There are many other factors to consider, however–even just with basic considerations like compatibility with everyday toothpaste.
Once researchers progress from testing in dental applications, it’s quite staggering to think of the implications this 3D printing technology could have in eliminating bacteria–it’s also amazing to consider how many lives could be saved in the future as individuals could avoid fighting off a multitude of different infections with the potential to do great harm. Let’s hear your thoughts on this new material. Discuss in the Anti-bacteria 3D Printing forum thread on 3DPB.com.[Sources: Advanced Functional Materials, International Business Times]
You May Also Like
$21M Round Fuels 2 Million Points of Metal 3D Printing Light from Seurat
Focused on disrupting centuries-old manufacturing techniques and challenging existing powder bed fusion (PBF) companies, Seurat Technologies has built a pioneering 3D metal printing process that can compete with the volumes,...
Bioprinting Firm REGEMAT3D Preps for IPO with Crowdfunding Campaign
In 2022, Spanish biotech company REGEMAT 3D will open an equity crowdfunding campaign on Crowdcube to add to the €402,500 ($457,000) raised during its first financing round. The funds will...
Sydney Bioprinting Firm Closes $25M Series B Round
In a Series B round led by Australia’s largest venture capital (VC) firm, Blackbird Ventures, Sydney-headquartered biotech startup Inventia raised $25 million (A$35 million). The company also landed in the...
3DPrint.com’s Top 10 Most Popular 3D Printing Stories of 2021
We finally made it to 2022! I feel like I said the same thing about 2021, but oh well. If you’ve been following along with us over the past week,...
View our broad assortment of in house and third party products.